Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06864728 · ClinicalTrials.gov registry record · NA
Diabetes Prevention in Hispanic Adults Using Constant Glucose Monitors
A NA study of Prediabetes / Type 2 Diabetes, sponsored by University of Texas at Austin.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06864728: Recruiting NA study of Prediabetes / Type 2 Diabetes, sponsored by University of Texas at Austin.
NCT06864728 is a NA study of Prediabetes / Type 2 Diabetes that is actively recruiting participants, run by University of Texas at Austin. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06864728, a NA study of Prediabetes / Type 2 Diabetes, is actively recruiting participants, sponsored by University of Texas at Austin.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is twofold: to see the impact of your environmental stress on daily glucose changes and to create an intervention using CGM to potentially decrease risk for diabetes. The aim of this study to develop an intervention to prevent diabetes in the Hispanic community and inform policies about social determinants of health.
Primary Outcome
measured by the Diabetes Knowledge questionnaire - Revised
Conditions Studied
Interventions
- BEHAVIORAL Video Diabetes Education
- BEHAVIORAL In person or virtual diabetes education
Study Locations (1)
Texas
- University of Texas at Austin - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-01-28 |
| Est. Completion | 2026-01-28 |
| Phase | NA |
What NCT06864728 shows while recruiting
NCT06864728 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Prediabetes / Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Video Diabetes Education is the first listed.
NCT06864728 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06864728 about?
NCT06864728 is a clinical study titled "Diabetes Prevention in Hispanic Adults Using Constant Glucose Monitors". The purpose of the study is twofold: to see the impact of your environmental stress on daily glucose changes and to create an intervention using CGM to potentially decrease risk for diabetes. The aim of this study to develop an intervention to prevent diabetes in the Hispanic community and inform po...
What is the current status of trial NCT06864728?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-01-28. Estimated completion is 2026-01-28.
What conditions does trial NCT06864728 study?
This clinical trial studies the following conditions: Prediabetes / Type 2 Diabetes.
What interventions are being tested in trial NCT06864728?
The interventions under investigation include: Video Diabetes Education (BEHAVIORAL), In person or virtual diabetes education (BEHAVIORAL).
Who is sponsoring clinical trial NCT06864728?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06864728 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prediabetes / Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06864728's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI